Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.50 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.49 |
| ▸ | CA7 | P43166 | 2/20 | 0.49 |
| ▸ | CXCR2 | P25025 | 6/20 | 0.46 |
| ▸ | RET | P07949 | 1/20 | 0.37 |
| ▸ | GRK5 | P34947 | 1/20 | 0.37 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8286615 | 0.80 | CA12 (0.56) | CA12CA1CA2CA9LMNA | |
| SCHEMBL8286607 | 0.78 | CA12 (0.53) | CA12CA1CA2CA9LMNA | |
| SCHEMBL7950710 | 0.76 | CXCR2 (0.52) | CA12CA1CA2CA9CA4 | |
| SCHEMBL7954682 | 0.74 | CXCR2 (0.50) | CA12CA1CA2CA9CA4 | |
| SCHEMBL10118553 | 0.72 | CA12 (1.00) | CA12CA1CA2CA9LMNA | |
| SCHEMBL29604473 | 0.71 | CXCR2 (0.47) | CA12CA1CA2CA9LMNA | |
| SCHEMBL22616552 | 0.71 | CXCR2 (0.47) | CA12CA1CA2CA9LMNA | |
| SCHEMBL7953007 | 0.70 | CXCR2 (0.46) | CA12CA1CA2CA9LMNA | |
| SCHEMBL8285729 | 0.70 | RET (0.43) | CA12CA1CA2CA9LMNA | |
| SCHEMBL7953169 | 0.70 | CXCR2 (0.49) | CA12CA1CA2CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100119613-A1 | PROCESS TO ACTIVATE EXTRACTS DERIVED FROM LIVING ORGANISMS USING LONG WAVE UV IRRADIATION AND COMPOSITIONS COMPRISING SAID ACTIVATED EXTRACT | MEDIZINISCHE UNIVERSITAT WIEN | 2010-05-13 | — | — | US | disclosed |
| WO-2007029121-A2 | NOVEL CYCLOPENT-2-EN-1-ONE DERIVATIVES WHICH ARE PPAR RECEPTOR MODULATORS, AND USE THEREOF IN PHARMACEUTICAL OR COSMETIC COMPOSITIONS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119613-A1 | PROCESS TO ACTIVATE EXTRACTS DERIVED FROM LIVING ORGANISMS USING LONG WAVE UV IRRADIATION AND COMPOSITIONS COMPRISING SAID ACTIVATED EXTRACT | ALOX15, ALOX5, ALOX12 | CA12 4767/4885CA1 4626/4885CA2 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.